Optimisation of in vitro assays for accurate risk assessment of T-cell responses to biologics with potential immune liabilities.

Rituxan (rituximab) - Roche

http://www.ncbi.nlm.nih.gov/pubmed/42762263

Catherine J Betts; Dean J Naisbitt; Georgia Wells; Katy Saide; Liam Farrell; Lonnie MacDonald; Sophie Grice; Xiaoli Meng

Sep 20, 2026